子宫内膜癌早期血清学筛查的研究进展
Research Progress in Early Serological Screening of Endometrial Cancer
DOI: 10.12677/ACM.2023.1381791, PDF,   
作者: 赵香连, 王海燕*：青海大学研究生院，青海 西宁
关键词: 子宫内膜癌；血清学标志物；Endometrial Cancer； Serological Markers
摘要: 子宫内膜癌(endometrial cancer, EC)是女性生殖系统最常见的恶性肿瘤之一。其发病率正逐年上升，然而多数EC患者早期无明显症状，不能尽早确诊，从而影响预后生存质量，因此探索子宫内膜癌的血清学标志物受到高度关注。本文是对子宫内膜癌早期血清学筛查的最新研究进展进行综合性叙述。
Abstract: Endometrial cancer (EC) is one of the most common malignant tumors in the female reproductive system. Its incidence rate is increasing year by year. However, most EC patients have no obvious symptoms in the early stage and cannot be diagnosed as soon as possible, which affects the quality of life after prognosis. Therefore, the exploration of serological markers of endometrial cancer is highly concerned. This article provides a comprehensive description of the latest research progress in early serological screening for endometrial cancer.
文章引用：赵香连, 王海燕. 子宫内膜癌早期血清学筛查的研究进展[J]. 临床医学进展, 2023, 13(8): 12777-12781. https://doi.org/10.12677/ACM.2023.1381791

参考文献

[1] Freddie, B., Jacques, F., Isabelle, S., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Emsal-Pınar-Topdağı, Y. and Yakup, K. (2016) Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA125 Levels in the Extent of Disease at Evaluation. The Eur-asian Journal of Medicine, 48, 192-198. [Google Scholar] [CrossRef] [PubMed]
[3] 李莉. 血小板参数、CA125、HE4与子宫内膜癌病理特征的相关性分析[D]: [硕士学位论文]. 兰州: 兰州大学, 2022.
[4] 徐慧, 张晶波, 刘建维, 等. 胰岛素抵抗及雌激素促进子宫内膜癌发生发展的机制研究[J]. 徐州医科大学学报, 2020, 40(12): 877-881.
[5] Sundar, S., Balega, J., Crosbie, E., et al. (2017) BGCS Uterine Cancer Guidelines: Recommendations for Practice. European Journal of Obstet-rics, Gynecology, and Reproductive Biology, 213, 71-97. [Google Scholar] [CrossRef] [PubMed]
[6] Van Hanegem, N., Prins, M.M.C., Bongers, M.Y., et al. (2015) The Accuracy of Endometrial Sampling in Women with Postmenopausal Bleeding: A Systematic Review and Me-ta-Analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 197, 147-155. [Google Scholar] [CrossRef] [PubMed]
[7] Braun, M.M., Overbeek-wager, E.A. and Grumbo, R.J. (2016) Diagnosis and Management of Endometrial Cancer. American Family Physician, 93, 468-474.
[8] Tanko, N.M., Linkov, F., Bapayeva, G., et al. (2021) Pipelle Endometrial Biopsy for Abnormal Uterine Bleeding in Daily Clinical Practice: Why the Approach to Patients Should Be Personalized? Journal of Personalized Medicine, 11, Article No. 970. [Google Scholar] [CrossRef] [PubMed]
[9] Bast, R.-C., Klug, T.-L., John, E.-S., et al. (1983) A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer. The New England Journal of Medi-cine, 309, 883-887. [Google Scholar] [CrossRef] 
[10] Duk, J.-M., Aalders, J.-G., Fleuren, G.-J., et al. (1986) CA125: A Useful Marker in Endometrial Carcinoma. American Journal of Obstetrics and Gynecology, 155, 1097-1102. [Google Scholar] [CrossRef] [PubMed]
[11] Bian, J., Sun, X.X., Li, B., et al. (2016) Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients with Endometrial Cancer. Technology in Cancer Research & Treatment, 16, 435-439. [Google Scholar] [CrossRef] [PubMed]
[12] 范余娟, 邹靖, 徐红, 等. 子宫内膜癌γ-synuclein表达和血清CA_(125)水平及与临床病理特征关系的研究[J]. 实用妇产科杂志, 2012, 28(3): 221-224.
[13] Ota, S., Sugiyama, T., Ushijima, K., et al. (2000) Successful Treatment of Two Patients with Recurrent Endometrial Cancer by Weekly Paclitaxel. Cancer Letters, 160, 9-12. [Google Scholar] [CrossRef] 
[14] Kirchhoff, C., Habben, I., Ivell, R., et al. (1991) A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors. Biology of Reproduction, 45, 350-357. [Google Scholar] [CrossRef] [PubMed]
[15] Kalogera, E., Scholler, N., Powless, C., et al. (2011) Correlation of Serum HE4 with Tumor Size and Myometrial Invasion in Endometrial Cancer. Gynecologic Oncology, 124, 270-275. [Google Scholar] [CrossRef] [PubMed]
[16] Li, X., Gao, Y.P., Tan, M.Z., et al. (2015) Expression of HE4 in Endometrial Cancer and Its Clinical Significance. Biomed Research International, 2015, Article ID: 437468. [Google Scholar] [CrossRef] [PubMed]
[17] Galgano, M.T., Hampton, G.M. and Frierson, H.F. (2006) Comprehen-sive Analysis of HE4 Expression in Normal and Malignant Human Tissues. Modern Pathology, 19, 847-853. [Google Scholar] [CrossRef] [PubMed]
[18] Quan, Q., Liao, Q.Q., Yin, W.C., et al. (2021) Serum HE4 and CA125 Combined to Predict and Monitor Recurrence of Type II Endometrial Carcinoma. Scientific Reports, 11, Article No. 21694. [Google Scholar] [CrossRef] [PubMed]
[19] 兰新志. 血清HE4、CA125和血浆D-二聚体在子宫内膜癌的表达及联合检测的临床价值[J]. 实验与检验医学, 2019, 37(5): 916-918.
[20] 董动丽, 顾劲松, 赵绍杰. 子宫内膜癌患者血清HE4、CA125水平变化及其意义[J]. 山东医药, 2017, 57(3): 73-75.
[21] Luo, G.P., Jin, K.Z., Deng, S.M., et al. (2020) Roles of CA19-9 in Pancreatic Cancer: Biomarker, Predictor and Promoter. Biochimica et Biophysica Acta. Reviews on Cancer, 1875, Article ID: 188409. [Google Scholar] [CrossRef] [PubMed]
[22] 孙艳艳, 井水, 杨大平, 等. 子宫内膜癌患者血清CA125、CA199、SCC-Ag表达水平及其临床意义[J]. 医学综述, 2022, 28(3): 615-618, 624.
[23] 马丽丽. 血清CA125、CA199和骨桥蛋白联合检测在子宫内膜癌中的临床应用价值[D]: [硕士学位论文]. 新乡: 新乡医学院, 2016.
[24] Fusetti, F., Pijning, T., Kalk, K.H., et al. (2003) Crystal Structure and Carbohydrate-Binding Properties of the Human Cartilage Glycoprotein-39. The Journal of Biological Chemistry, 278, 37753-37760. [Google Scholar] [CrossRef] 
[25] 尹绪爱, 干宁. YKL-40在妇科恶性肿瘤中的表达和意义[J]. 国际妇产科学杂志, 2013, 40(2): 146-148, 155.
[26] 钟俊杰. CA125、CA153、CA199在卵巢癌及其转移早期诊断中作用的探讨[J]. 中外医学研究, 2013, 11(3): 51-53.
[27] Bonneh-Barkay, D., Bissel, S.J., Kofler, J., et al. (2011) As-trocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation. Brain Pathol-ogy (Zurich, Switzerland), 22, 530-546. [Google Scholar] [CrossRef] [PubMed]
[28] 魏鹏, 骆爱萍, 丁芳, 等. YKL-40表达与子宫内膜癌临床病理因素的关系[J]. 癌症进展, 2013, 11(3): 212-218.

为你推荐